Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler
R B
RB
Infectious Disease Unit, Auckland Hospital, NZ.
Beeching
N J
NJ
Eales
M
M
Fraser
A G
AG
Wells
A U
AU
D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D015767:Mefloquine / Q000031:analogs & derivatives; D010963:Plasmodium falciparum / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D011739:Pyrimethamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D011804:Quinolines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000008:administration & dosage* / Q000627:therapeutic use*; D000096926:Benzenesulfonamides
D004338:Drug Combinations; D015767:Mefloquine; D011739:Pyrimethamine; D011804:Quinolines; D013413:Sulfadoxine; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; C046846:mefloquine-sulfadoxine-pyrimethamine; D000096926:Benzenesulfonamides